1
|
Hartman R, Xue Y, Singer S, Markossian T, Joyce C, Mostaghimi A. Modelling the value of risk‐stratified skin cancer screening of asymptomatic patients by dermatologists. Br J Dermatol 2020; 183:509-515. [DOI: 10.1111/bjd.18816] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/18/2019] [Indexed: 12/11/2022]
Affiliation(s)
- R.I. Hartman
- Department of Dermatology Brigham and Women's Hospital and Harvard Medical School Boston MA USA
| | - Y. Xue
- Harvard Combined Dermatology Residency Training Program Boston MA USA
| | - S. Singer
- Department of Dermatology Brigham and Women's Hospital and Harvard Medical School Boston MA USA
| | - T.W. Markossian
- Department of Public Health Sciences Loyola University Stritch School of Medicine Chicago IL USA
| | - C. Joyce
- Department of Public Health Sciences Loyola University Stritch School of Medicine Chicago IL USA
| | - A. Mostaghimi
- Department of Dermatology Brigham and Women's Hospital and Harvard Medical School Boston MA USA
| |
Collapse
|
2
|
Hartman R, Xue Y, Markossian T, Joyce C, Mostaghimi A. 253 Modeling the value of risk stratified skin cancer screening by dermatologists in the U.S. population. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
3
|
Oatis WS, Nonzee N, Markossian T, Shankaran V, McKoy J, Evens A, Gordon L, Winter J, Calhoun E, Bennett CL. Interpreting out-of-pocket expenditures for cancer patients: The importance of considering baseline household income information. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.6541] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
6541 Background: Few studies have examined cancer-related out-of-pocket costs (expenses resulting from cancer morbidity and treatment that are not covered by insurance) as a function of baseline household income. We report income-adjusted out-of-pocket cost ratios for 50 patients with lymphoma and 156 patients with breast cancer. Methods: Patients with lymphoma or breast cancer provided 3-month retrospective documentation of cancer-related out-of-pocket costs. Costs were adjusted for income by dividing monthly costs by monthly household income. Direct medical costs include costs related to medications, doctor visits, and hospital stays. Direct non-medical costs are cancer-related peripheral costs, such as transportation and meals. Indirect costs are costs due to lost income. Results: Of our study patients, 83% were Caucasian, 65% were married, 53% were employed, and 65% had at least a bachelor's degree. All patients were undergoing active treatment and had insurance. Mean monthly out-of-pocket costs for patients with lymphoma were slightly greater than for those with breast cancer ($1,888 vs $1,455, respectively). Among patients with an annual income of $30,000 or less, the total monthly out-of-pocket costs were more than 3 times the monthly household income for patients with lymphoma and equal to the monthly household income for patients with breast cancer. The total mean income-adjusted cost ratio was 1.75 for patients with aggressive non-Hodgkin lymphoma versus 0.42 and 0.61 for those with indolent non-Hodgkin lymphoma or Hodgkin disease, respectively. Conclusions: Cancer-related out-of-pocket expenses disproportionately affect lower-income individuals with lymphoma or breast cancer and are primarily driven by the financial burden of co-payments for medical care. Future studies should evaluate out-of-pocket costs in relation to household income to determine more accurately the economic burden of cancer. [Table: see text] No significant financial relationships to disclose.
Collapse
Affiliation(s)
- W. S. Oatis
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - N. Nonzee
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - T. Markossian
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - V. Shankaran
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - J. McKoy
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - A. Evens
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - L. Gordon
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - J. Winter
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - E. Calhoun
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| | - C. L. Bennett
- Northwestern University, Chicago, IL; University of Illinois at Chicago, Chicago, IL
| |
Collapse
|